SatiVite
- Company typePrivate
- Founded2021
- HeadquartersAcacia Ridge, Australia
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What SatiVite does
SatiVite Pty Ltd is an Australian, privately held medicinal cannabis supplier founded in 2021 and headquartered in Acacia Ridge, Queensland. The company operates within the TGA regulatory framework, selling cannabis-based products that can only be dispensed through licensed pharmacies to patients holding a valid prescription and TGA approval under pathways such as SAS-B or Authorised Prescriber schemes. SatiVite serves three interlocking customer segments: patients with chronic medical conditions who have exhausted conventional treatments, medical prescribers (GPs and specialists) navigating TGA approval workflows, and pharmacists requiring support with dispensing compliance across varying state and territory requirements. The go-to-market is B2B enterprise field sales targeting healthcare professionals, supported by a dedicated professional ordering portal that requires TGA documentation before processing orders, and educational content distributed through the company website. Revenue is generated on a prescription-recurring basis via pharmacy dispensing rather than direct-to-consumer channels.
The company's core product is its portfolio of medicinal cannabis offerings differentiated by the proprietary SatiVite Can, a nitrogen-sealed packaging format designed to extend shelf life and reduce packaging waste relative to the industry-standard plastic packaging. The company also emphasizes regenerative and sustainable cultivation practices, and its brand positioning is anchored in a patient-led narrative — founder Mike Cleary, who established the company following a 2012 motorcycle accident that left him with chronic pain, is one of two patient-founders among three co-founders spanning corporate, medical, and agricultural backgrounds. SatiVite holds memberships with the Australian Medicinal Cannabis Association (AMCA) and Australian Sustainable Plastics (ASP), and operates under the Australian Privacy Principles (Privacy Act 1988). Pricing is not publicly disclosed and no funding rounds, M&A activity, public listing, mobile applications, or API products are indicated.
SatiVite firmographics
Firmographics- Name
- SatiVite
- Legal name
- SatiVite Pty Ltd
- Website
- https://sativite.com.au
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
SatiVite industry classification
Industry- Product category
- Medicinal Cannabis Products
- NAICS
- Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Medical Cannabis Delivery & Online Ordering (CRANAGAG)
Keywords
Where SatiVite is headquartered
LocationHeadquarters
- HQ city
- Acacia Ridge
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
SatiVite business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Medicinal Cannabis Product Sales: SatiVite generates revenue through the sale of medicinal cannabis products to patients via healthcare professional prescriptions. Products are distributed through pharmacies after TGA approval requirements are met. The company operates as a licensed Australian medicinal cannabis supplier.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
SatiVite product offering
Product offeringCore offering
SatiVite develops, cultivates and supplies medicinal cannabis products for the Australian market under TGA regulatory frameworks. Products are distributed through licensed pharmacies after TGA approval (SAS-B or Authorised Prescriber pathways) and valid prescriptions are verified. The company differentiates through proprietary nitrogen-sealed can packaging designed to extend shelf life and reduce plastic packaging waste, combined with sustainable and regenerative cultivation practices.
Product overview
SatiVite is a patient-led, Australia-based medicinal cannabis company offering a portfolio of cannabis-based products. The company focuses on providing high-quality medicinal cannabis products with sustainable packaging solutions. Their main offering includes medicinal cannabis products for patients, supported by guidance for prescribers and pharmacists. The SatiVite Can represents their proprietary nitrogen-sealed packaging innovation, which differentiates their product presentation from industry-standard plastic packaging.
Differentiator
Problem solved
Functional benefit
Products and services
- SatiVite Medicinal Cannabis Products A range of medicinal cannabis products developed by SatiVite, designed to provide treatment options for patients with chronic medical conditions where conventional pharmaceutical treatments have failed or caused intolerable side effects. Products are dispensed through licensed Australian pharmacies after TGA approval via SAS-B or Authorised Prescriber schemes. The company also provides guidance for prescribers and pharmacists on prescribing and dispensing processes.
Companies that use SatiVite
Customer profileSegments3 records
Ideal customer profiles3 records
SatiVite technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
SatiVite partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor.
- Australian Medicinal Cannabis Association (AMCA)minorSatiVite displays membership with the Australian Medicinal Cannabis Association (AMCA), an industry body representing the medicinal cannabis sector in Australia. Membership indicates compliance with industry standards and participation in the broader medicinal cannabis community.
- Australian Sustainable Plastics (ASP)minorSatiVite maintains affiliation with Australian Sustainable Plastics (ASP), indicating commitment to sustainable packaging practices. This aligns with their environmentally conscious approach to product packaging using nitrogen-sealed cans.
Scale indicators2 records
Recent moves5 records
Expansion highlights4 records
SatiVite competitors and assessment
Company assessmentDirect peers
- Bod Australia: ASX-listed Australian medicinal cannabis and health products company distributing cannabis-based therapeutics through healthcare professionals and pharmacies. Comparable in B2B prescriber-led distribution model and Australian market focus.
- MGC Pharmaceuticals: Australia- and Europe-focused medicinal cannabis company developing and supplying cannabinoid-based pharmaceuticals through prescription and pharmacy channels. Comparable in cross-border B2B medicinal cannabis distribution and regulatory pathway.
- Zelira Therapeutics: Australia-based medicinal cannabis company commercialising TGA-approved cannabinoid formulations for chronic conditions through pharmacy distribution. Comparable in patient-led product development and Australian pharmacy-led GTM.
- Cann Group: ASX-listed Australian medicinal cannabis cultivator and manufacturer with TGA licences, distributing products through pharmacies and prescribers. Closely comparable in regulatory pathway, Australian-only footprint, and pharmacy-based distribution.
- Althea Group: Australia-based medicinal cannabis company supplying TGA-approved products via the Special Access Scheme and pharmacy dispensing. Direct competitor targeting the same chronic-condition patient and prescriber segments as SatiVite.
- Little Green Pharma: ASX-listed Australian medicinal cannabis producer supplying TGA-approved flower and oil products to patients via pharmacies. Direct competitor in the same Australian medicinal cannabis supply channel with overlapping prescriber and pharmacy distribution model.
- AusCann Group Holdings: Australian medicinal cannabis company focused on producing and supplying TGA-approved cannabinoid medicines to patients via pharmacies. Comparable in cultivation, regulatory positioning, and pharmacy distribution strategy.
- THC Global Group: Australian medicinal cannabis producer with TGA manufacturing licences supplying cannabis extracts and flower through pharmacy and prescriber channels. Comparable in production licensing, Australian distribution, and prescriber education focus.
- Incannex Healthcare: ASX-listed Australian company developing and commercialising medicinal cannabinoid products for chronic conditions through prescriber and pharmacy channels. Comparable in target patient segments and Australian regulatory positioning.
- Medlab Clinical: Australian pharmaceutical company with a medicinal cannabis portfolio, supplying TGA-approved products via healthcare professionals and specialty channels. Comparable in B2B prescriber channel and TGA-licensed product positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
SatiVite social profiles
Digital presenceSatiVite compliance and trust
Trust signalCompliance1 record
SatiVite financial estimates
Financial estimateRevenue estimate
Valuation estimate
SatiVite leadership team
Management profileNumber of profiles
Profiles1 record
SatiVite funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SatiVite M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SatiVite
What does SatiVite do?
SatiVite develops, cultivates and supplies medicinal cannabis products for the Australian market under TGA regulatory frameworks. Products are distributed through licensed pharmacies after TGA approval (SAS-B or Authorised Prescriber pathways) and valid prescriptions are verified. The company differentiates through proprietary nitrogen-sealed can packaging designed to extend shelf life and reduce plastic packaging waste, combined with sustainable and regenerative cultivation practices.
Is SatiVite a public or private company?
SatiVite is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SatiVite founded?
SatiVite was founded in 2021. It employs 1 to 10 people.
Where is SatiVite based?
SatiVite is headquartered in Acacia Ridge, Australia, in the Oceania region.
How does SatiVite make money?
One revenue line is on record: medicinal Cannabis Product Sales.
Who are SatiVite's main competitors?
Direct peers on record are Bod Australia, MGC Pharmaceuticals, Zelira Therapeutics, Cann Group, Althea Group, Little Green Pharma, AusCann Group Holdings, THC Global Group, Incannex Healthcare and Medlab Clinical.
Does SatiVite have an API?
No public API is recorded for SatiVite.
What industry is SatiVite in?
SatiVite's product category is Medicinal Cannabis Products. Its primary akta.pro industry code is CRANAGAG, Medical Cannabis Delivery & Online Ordering. Its NAICS code is 325411 and its SIC code is 2833.